Acumen Hypotension Prediction Index (HPI) Feature Software vs Eko Low Ejection Fraction Tool (ELEFT)
AI Verdict
Choose Acumen Hypotension Prediction Index (HPI) Feature Software if…
Choose Acumen HPI if your clinical focus is on real-time, proactive hemodynamic management in acute care settings like the OR or ICU. This tool is ideal for anesthesiologists and critical care specialists who need to predict and prevent hypotensive events up to 15 minutes before they occur, leveraging advanced machine learning on blood pressure waveforms to optimize patient stability during critical periods.
View Acumen Hypotension Prediction Index (HPI) Feature Software →Choose Eko Low Ejection Fraction Tool (ELEFT) if…
Choose Eko ELEFT if you require a non-invasive, AI-powered screening tool for early detection of low ejection fraction during routine physical exams. This solution is best suited for primary care physicians and cardiologists who aim to quickly identify patients at risk for heart failure using an integrated digital stethoscope, enabling timely referrals and interventions in an outpatient setting.
View Eko Low Ejection Fraction Tool (ELEFT) →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Acumen Hypotension Prediction Index (HPI) Feature Software | Eko Low Ejection Fraction Tool (ELEFT) |
|---|---|---|
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Eko Low Ejection Fraction Tool (ELEFT)Eko ELEFT offers a more streamlined and non-invasive workflow, integrating with digital stethoscopes to provide results in approximately 15 seconds during routine physical exams. Acumen HPI, while powerful, is integrated into an advanced monitoring platform and requires either invasive or non-invasive cuff monitoring, suggesting a more complex setup for critical care environments. The quick, non-invasive nature of ELEFT makes it highly usable for broad screening.
Clinical Value
Acumen Hypotension Prediction Index (HPI) Feature SoftwareAcumen HPI has demonstrated a significant reduction in the incidence, duration, and severity of intraoperative hypotension, directly impacting patient outcomes in critical settings. Eko ELEFT aids in the early detection of low ejection fraction, which is crucial for identifying heart failure risk, but Acumen HPI's stated reduction in adverse events provides a more direct and quantifiable clinical impact.
Pricing & Value
TieBoth tools require direct contact with the vendor for pricing information, making it impossible to compare their cost-effectiveness or overall value proposition. Without transparent pricing or detailed cost-benefit analyses, a definitive winner cannot be determined. Both are positioned as enterprise solutions.
Enterprise Readiness
TieBoth tools are FDA-cleared, HIPAA compliant, and have Business Associate Agreements (BAAs), indicating strong enterprise readiness. Acumen HPI integrates with an existing advanced monitoring platform, while Eko ELEFT is a cloud-based solution part of an enterprise platform, showing both are designed for seamless integration into healthcare systems.
Innovation
Acumen Hypotension Prediction Index (HPI) Feature SoftwareAcumen HPI is described as a 'first-of-its-kind technology' that uses machine learning to predict and help clinicians treat hemodynamic instability up to 15 minutes before a hypotensive event. While Eko ELEFT's AI integration with stethoscopes is innovative for point-of-care diagnostics, Acumen HPI's predictive and proactive treatment guidance in critical care represents a higher degree of novel innovation.
Support & Docs
TieBoth Edwards Lifesciences and Eko Health are established medical technology companies expected to provide comprehensive support and documentation for their products. While specific comparative details on the quality or extent of their support are not available in the provided data or general web searches, both offer user manuals and support resources.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Acumen Hypotension Prediction Index (HPI) Feature Software | Eko Low Ejection Fraction Tool (ELEFT) |
|---|---|---|
| Name | Acumen Hypotension Prediction Index (HPI) Feature Software | Eko Low Ejection Fraction Tool (ELEFT) |
| Company | Edwards Lifesciences | Eko Health |
| Primary Function | Predicts and alerts clinicians to the likelihood of a hypotensive event before it occurs, aiding in proactive hemodynamic management. | Aids clinicians in the early detection of low ejection fraction, a key indicator of heart failure, during routine physical exams. |
| Key Technology/Method | Machine learning algorithms for predictive analysis of blood pressure waveforms. | AI algorithm that analyzes ECG and heart sound recordings. |
| Integration/Compatibility | Edwards Lifesciences HemoSphere advanced monitoring platform; compatible with invasive (arterial line) and non-invasive (Acumen IQ cuff) monitoring. | Eko digital stethoscopes; part of Eko's SENSORAu2122 platform. |
| Target Specialties | Anesthesiology, Critical Care, Emergency Medicine | Cardiology, Family Medicine, Internal Medicine |
Videos
Demos, reviews, and walkthroughs featuring Acumen Hypotension Prediction Index (HPI) Feature Software and Eko Low Ejection Fraction Tool (ELEFT).
Frequently Asked Questions
More Comparisons
More matchups featuring Acumen Hypotension Prediction Index (HPI) Feature Software or Eko Low Ejection Fraction Tool (ELEFT)
- Eko Low Ejection Fraction Tool (ELEFT) vs EchoNext
- Eko Low Ejection Fraction Tool (ELEFT) vs PMcardio
- Eko Low Ejection Fraction Tool (ELEFT) vs Cardiomo
- Acumen Hypotension Prediction Index (HPI) Feature Software vs Cardiomo
- Eko Low Ejection Fraction Tool (ELEFT) vs KardiaPro
- Acumen Hypotension Prediction Index (HPI) Feature Software vs KardiaPro
Backers
Who funded each tool's parent company.